Comparing surgical approaches for early-stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study compares two surgical approaches for removing early-stage lung cancer (2-3 cm) from the outer part of the lung. It aims to see if removing only the affected segment (segmentectomy) is as effective as removing a larger portion of the lung (lobectomy), while potentially preserving more lung function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with early-stage non-small cell lung cancer (stage IA3) with a tumor size between 2 and 3 cm.
- Your tumor is in the outer part of the lung and can be removed by surgery.
- You are in good overall health with adequate lung function for surgery.
- The cancer has not spread to nearby lymph nodes or distant organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of surgery for small, early-stage lung cancers that are deep inside the lung. It aims to see if removing only a small part of the lung (segmentectomy) works as well as removing a whole lobe (lobectomy), which may help patients recover faster and preserve more lung function.
This study compares two lung cancer surgeries: segmentectomy (removing only the part of the lung with the tumor) and lobectomy (removing the entire lobe). It is for people with early-stage non-small cell lung cancer that is 2–3 cm and more solid than hazy on a CT scan. The goal is to see which surgery works better while preserving lung function.
This trial looks back at medical records to compare different ways of performing a segmentectomy (removing a small part of the lung) for early-stage lung cancer. It aims to see which approach might lead to better outcomes for patients like you.
This trial tests a new surgical technique to remove small, early-stage lung cancers that are located deep within the lung tissue. The goal is to remove only the affected area while preserving as much healthy lung as possible.
This study compares two types of lung cancer surgery—removing just the tumor section (segmentectomy) or the whole lobe (lobectomy)—done through small cuts (minimally invasive). The goal is to see which approach leads to better daily living and recovery for early-stage lung cancer patients.
This study compares two treatments—removing only part of the lung (sublobar resection) versus a focused radiation approach (stereotactic ablative radiotherapy)—for early-stage non-small cell lung cancer. It aims to see which option works better with fewer problems for the right patients.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.